Financhill
Back

Bellevue Life Sciences Acquisition Quote, Financials, Valuation and Earnings

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Sell
16

BLAC
Bellevue Life Sciences Acquisition

Last Price:
11.85
Seasonality Move:
2.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Bellevue Life Sciences Acquisition Price Quote

$11.85
+0.55 (+5.24%)
(Updated: December 12, 2024 at 5:14 AM ET)

Bellevue Life Sciences Acquisition Key Stats

Sell
16
Bellevue Life Sciences Acquisition (BLAC) is a Sell

Day range:
$11.26 - $11.85
52-week range:
$10.45 - $13.40
Dividend yield:
0%
P/E ratio:
226.00
P/S ratio:
0.00
P/B ratio:
3.06%

Volume:
2.8K
Avg. volume:
8.6K
1-year change:
8.13%
Market cap:
$45.7M
Revenue:
$0
EPS:
$-0.1

How Much Does Bellevue Life Sciences Acquisition Make?

Data Unavailable

Is Bellevue Life Sciences Acquisition Growing As A Company?

Data Unavailable

Bellevue Life Sciences Acquisition Stock Price Performance

What Is Bellevue Life Sciences Acquisition 52-Week High & Low?

Bellevue Life Sciences Acquisition Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bellevue Life Sciences Acquisition?

Is Bellevue Life Sciences Acquisition Cash Flow Positive?

Bellevue Life Sciences Acquisition Return On Invested Capital

Data Unavailable

Bellevue Life Sciences Acquisition Earnings Date & Stock Price

Bellevue Life Sciences Acquisition Competitors

Bellevue Life Sciences Acquisition Dividend Yield

Bellevue Life Sciences Acquisition Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many BLAC shares are owned by institutional investors?
    3.7M BLAC shares are owned by institutional investors
  • How many BLAC shares are owned by insiders?
    120K BLAC shares are owned by insiders